Clinical and Laboratory Parameters in Children with ITP – a Prospective Follow-up study

אוסאמה טנוס 1 Ariel Koren 2 Tali Dujovny 2 Harel Eitam 3 Raul Colodner 3 Carina Levin 2
1Pediatric Ward A, Emek Medical Center
2Pediatric Hematology Unit, Emek Medical Center
3Hematology Laboratory, Emek Medical Center

Introduction

Immune Thrombocytopenia (ITP) is one of the most common hematological abnormalities in children; despite the extremely low platelet count the symptoms are generally mild. Some studies have argued that a compensatory pro-coagulant plasmatic state with a protective effect exist in these patients. Our study aims to investigate this pro-coagulant state in pediatric ITP patients.

Patients and Methods

Pediatric ITP patients treated at Emek Medical Center were included. Bleeding score and laboratory parameters including platelet (Plt) count, PT- aPTT, von Willebrand factor (vWF) and Factor VIII activity at 2 different points, disease onset and during follow-up, were assessed.

Results

Thirty seven patients were included (24M/13F); median age was 3.3 (0.7-22.7) yr. Eight pts (22%) had a bleeding score of 3 (more than skin ) or more. Five patients were treated with steroids or IVIG.

Patients with an acute disease (12 mo), (p<0.025). The severity of bleeding was lower in Arab pts than in Jewish ones (p<0.02). Seventeen pts were evaluated at two time-points. The mean Plt count and vWF were 25.3 K/µl, 165.6% at point 1 and 199.1K/µl, 146.6% at point 2; respectively. Platelet count significantly increased and vWF significantly decreased between time points 1 and 2 among our patients (Z=-3.41, p<0.001; Z=2.23, p<0.03).

Discussion

A compensatory pro-coagulant state with increased vWF was found in our cohort at enrollment and declined when platelet count increased. This might explain the scarcity of severe bleeding in pediatric ITP patients.

אוסאמה טנוס
אוסאמה טנוס
Emek Medical Center








Powered by Eventact EMS